Home
Gøril Knutsvik's picture

Gøril Knutsvik

Guest Researcher
  • E-mailgoril.knutsvik@uib.no
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). Age-related phenotypes in breast cancer: A population-based study. International Journal of Cancer.
  • Show author(s) (2023). Vessel size as a marker of survival in estrogen receptor positive breast cancer. Breast Cancer Research and Treatment.
  • Show author(s) (2023). Hypoxia induced responses are reflected in the stromal proteome of breast cancer. Nature Communications. 1-16.
  • Show author(s) (2022). PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nature Communications. 1-19.
  • Show author(s) (2022). Neurogenesis and angiogenesis are associated features of aggressive breast cancer . bioRxiv.
  • Show author(s) (2021). Detection and significance of small and low proliferation breast cancer. Journal of Medical Screening. 1-6.
  • Show author(s) (2020). Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups. Scientific Reports. 14 pages.
  • Show author(s) (2019). Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes. The journal of pathology. Clinical research. 69-82.
  • Show author(s) (2017). Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. PLOS ONE. 1-15.
  • Show author(s) (2017). Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer. Scientific Reports. 1-12.
  • Show author(s) (2016). Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. Journal of Clinical Pathology. 313-319.
  • Show author(s) (2016). QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas. Modern Pathology. 1485-1491.
  • Show author(s) (2016). Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer. PLOS ONE.
  • Show author(s) (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. OncoTarget. 10634-10645.
  • Show author(s) (2014). Evaluation of Ki67 expression across distinct categories of breast cancer specimens: A Population-based study of matched surgical specimens, core needle biopsies and tissue microarrays. PLOS ONE.
Doctoral dissertation
  • Show author(s) (2016). Biomarkers in breast cancer, with special focus on tumor cell proliferation.
Abstract
  • Show author(s) (2013). Proliferation markers PHH3, Ki67 and mitotic count all show significant associations with features of aggressive breast carcinomas and reduced survival. Modern Pathology. 50A-50A.
  • Show author(s) (2013). Proliferation markers PHH3, Ki67 and Mimtotic count all show significant associations with features of aggressive breast carcinomas and reduced survival. Laboratory Investigation. 50A-50A.
  • Show author(s) (2012). Prognostic impact of proliferation markers Ki-67, PHH3 and mitotic count in breast carcinomas. Virchows Archiv. S5-S5.

More information in national current research information system (CRIStin)